Hepatitis B Virus-Based Vectors Allow the Elimination of Viral Gene Expression and the Insertion of Foreign Promoters

Human Gene Therapy

Volumn 15, Issue 2, 2004, Pages 203-210

  Untergasser, Andreas ^a,b   Protzer, Ulrike ^a,b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Inst Med Mikrobiol Immunol Hyg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; VIRUS VECTOR;

ARTICLE; GENE CONSTRUCT; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE INSERTION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HEPATITIS B VIRUS; HEPATOMA CELL; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; KNOCKOUT GENE; LIVER CELL; NONHUMAN; OPEN READING FRAME; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENE; VIRUS GENE; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINANT;

GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENETIC VECTORS; HELPER VIRUSES; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; PLASMIDS; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TRANSGENES;

DNA VIRUSES; HEPATITIS B VIRUS; INSERTION SEQUENCES; RNA VIRUSES;

EID: 1142273135     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303404772680001     Document Type: Article

References (19)

1. BARTENSCHLAGER, R., JUNKER-NIEPMANN, M., and SCHALLER, H. (1990). The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J. Virol. 64, 5324-5332.
2. CHAISOMCHIT, S., TYRRELL, D.L.J., and CHANG, L.-J. (1997). Development of replicative and nonreplicative hepatitis B virus vectors. Gene Ther. 4, 1330-1340.
3. CHANG, C.M., JENG, K.S., HU, C.P., LO, S.J., SU, T.S., TING, L.P., PFAFF, E., SALFELD, J., and SCHALLER, H. (1987). Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J. 6, 675-680.
4. COSTA, R.H., and GRAYSON, D.R. (1991). Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res. 19, 4139-4145.
5. GANEM, D. (1999). An advance in liver-specific gene delivery (commentary). Proc. Natl. Acad. Sci. U.S.A. 96, 11696-11697.
6. GANEM, D., and SCHNEIDER, R.J. (2001). Hepadnaviridae: The Viruses and Their Replication. In Fields Virology. D.M. Knipe and P.M. Howley, eds. (Lippincott Williams & Wilkins, Philadelphia) pp. 2923-2969.
7. GRIPON, P., DIOT, C., and GUGUEN-GUILLOUZO, C. (1993). Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration. Virology 192, 534-540.
8. HIRSCH, R.C., LAVINE, J.E., CHANG, L.J., VARMUS, H.E., and GANEM, D. (1990). Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 344, 552-555.
9. HORWICH, A.L., FURTAK, K., PUGH, J., and SUMMERS, J. (1990). Synthesis of hepadnavirus particles that contain replication-defective duck hepatitis B virus genomes in cultured HuH7 cells. J. Virol. 64, 642-650.
10. KLÖCKER, U., SCHULTZ, U., SCHALLER, H., and PROTZER, U. (2000). Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication. J. Virol. 74, 5525-5533.
11. KLÖCKER, U., OBERWINKLER, H., KURSCHNER, T., and PROTZER, U. (2003). Presence of replicating virus in recombinant hepadnavirus stocks results from recombination and can be eliminated by the use of a packaging cell line. J. Virol. 77, 2873-2881.
12. LAVINE, J., HIRSCH, R., and GANEM, D. (1989). A system for studying the selective encapsidation of hepadnavirus RNA. J. Virol. 63, 4257-4263.
13. NASSAL, M., JUNKER NIEPMANN, M., and SCHALLER, H. (1990). Translational inactivation of RNA function: Discrimination against a subset of genomic transcripts during HBV nucleocapsid assembly. Cell 63, 1357-1363.
14. OBERT, S., ZACHMANN-BRANDT, B., DEINDL, E., TUCKER, W., BARTENSCHLAGER, R., and SCHALLER, H. (1996). A spliced hepadnaviral RNA that is essential for virus replication. EMBO J. 15, 2565-2574.
15. PROTZER, U., NASSAL, M., CHIANG, P.W., KIRSCHFINK, M., and SCHALLER, H. (1999). Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc. Natl. Acad. Sci. U.S.A. 96, 10818-10823.
16. SCHULZE-BERGKAMEN, H., UNTERGASSER, A., DAX, A., VOGEL, H., BUCHLER, P., KLAR, E., LEHNERT, T., FRIESS, H., BUCHLER, M.W., KIRSCHFINK, M., STREMMEL, W., KRAMMER, P.H., MULLER, M., and PROTZER, U. (2003). Primary human hepatocytes: A valuable tool for investigation of apoptosis and hepatitis B virus infection. J. Hepatol. 38, 736-744.
17. SPRINZL, M., OBERWINKLER, H., SCHALLER, H., and PROTZER, U. (2001). Hepatitis B virus genome transfer with adenoviral vectors into cultured cells and mice: Crossing the species barrier. J. Virol. 75, 5108-5118.
18. VON WEIZSÄCKER, F., KOCK, J., WIELAND, S., BECK, J., NASSAL, M., and BLUM, H.E. (2002). Cis-preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase pre-assembly complex. Hepatology 35, 209-216.
19. ZOULIM, F., SAPUTELLI, J., and SEEGER, C. (1994). Woodchuck hepatitis virus X protein is required for viral infection in vivo. J. Virol. 68, 2026-2030.